Clinical Trials Sponsored by Profil GmbH, Neuss, Germany

Total 6 results

Sanofi
Profil GmbH, Neuss, Germany

Completed

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 (RESTORE)

Diabetes Mellitus, Type 2

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Medizinische Hochschule Hannover, Germany, Prof. Dr. Arndt Vogel; MSD Sharp...

Not yet recruiting

Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer (TRAP-BTC)

Biliary Tract Cancer | HER2 Gene Mutation
Albert Christian Ludolph, Prof.
Nutritia GmbH, 91052 Erlangen, Germany

Completed

Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS) (TOLCAL)

Amyotrophic Lateral Sclerosis

Germany
Charite University, Berlin, Germany
Prof. Dr. Stefan M. Gold; Prof. Dr. Soyoung Q Park; Dr. Ulrike Grittner; Motognosis...

Recruiting

Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation (MOTIVADE)

Depressive Disorder, Major

Germany
Pascoe Pharmazeutische Praeparate GmbH
Institut für Empirische Gesundheitsökonomie, Prof. Dr. Dr.med. Reinhard Rychlik...

Completed

Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®

Nervous Restlessness
Institut für Klinische Krebsforschung IKF GmbH...
Merck Sharp & Dohme LLC; Medizinische Hochschule Hannover, Germany, Prof. Dr...

Active, not recruiting

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Hepatocellular Carcinoma

Germany

Clinical Trials Sponsored by Profil GmbH, Neuss, Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations